Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery | MicrobiomeTrials← Back to trialsNCT07750275
Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2021-01-01Est. Completion: 2026-12
Enrollment target: 800 participants Locations- University of Molise, Campobasso, CB, Italy
Other microbiome trials you might be interested in
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Biphenotypic LeukemiaAcute Undifferentiated LeukemiaCLL (Chronic Lymphocytic Leukemia)Chronic Myeloid Leukemia (CML)MDS (Myelodysplastic Syndrome)Non-Hodgkin LymphomasHodgkins LymphomaCutaneous T Cell Lymphomas (CTCL)
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marro…
Duarte, United StatesEst. completion Jul 14, 2026
Recruiting
Perforated Peptic UlcerPeptic Ulcer PerforationDuodenal Ulcer PerforationGastric Ulcer Perforation
Peptic ulcer perforation is a serious complication of peptic ulcer disease that requires urgent surgical treatment. The …
Multiple LocationsEst. completion Oct 2027
Esophageal AchalasiaEsophageal Motility DisordersGastroesophageal Reflux
Achalasia is a disorder of the esophagus in which the muscular valve between the esophagus and the stomach fails to rela…
Minya, EgyptEst. completion Sep 20, 2028